| Watchers | 27,019 |
| 52-Wk Low | $1.35 |
| 52-Wk High | $23.60 |
| Market Cap | $3.36M |
| Volume | 42,754.00 |
| 52-Wk High | $23.60 |
| 52-Wk Low | $1.35 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Altamira Therapeutics Ltd market cap is $3.36M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Altamira Therapeutics Ltd 52 week high is $23.60 as of May 10, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Altamira Therapeutics Ltd 52 week low is $1.35 as of May 10, 2024.
Altamira Therapeutics Ltd stock price today is $1.50.
Altamira Therapeutics Ltd stock price yesterday was $1.47.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Altamira Therapeutics Ltd’s P/E ratio is -0.06.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Altamira Therapeutics Ltd P/B ratio is -5.8502.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Altamira Therapeutics Ltd 50-day moving average is $1.80.
Altamira Therapeutics Ltd has 12 employees.